Human Papilloma Virus (HPV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Human Papilloma Virus (HPV) Tests Market Report Overview
The Human Papilloma Virus (HPV) tests market size will be valued at $406.3 million in 2023. The market will decline at a CAGR of over 1% during 2023-2033. Human papillomavirus tests are primarily used to screen for cervical cancer and/or identify women who may be at increased risk of cervical cancer. The HPV test determines whether a woman’s cervical cells are infected with a high-risk type of human papillomavirus (HPV).
Human Papilloma Virus Tests Market Outlook, 2023-2033 ($ Million)
Buy the Full Report for More Insights into the Human Papilloma Virus Tests Market Forecast
Download a Free Report Sample
The human papilloma virus tests market research report helps understand the quantitative market trends within the in vitro diagnostics therapeutic area. It discusses in detail the impact of COVID-19 on the HPV test market for the year 2020 and beyond.
Market Size (2023) | $406.3 Million |
CAGR (2023-2033) | <(1)% |
Forecast Period | 2024-2033 |
Historical Period | 2015-2023 |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Key Segments | · Human Papilloma Virus (HPV) Nucleic Acid Amplification Tests (NAATs)
· Other Human Papilloma Virus (HPV) Test Kits |
Leading Companies | · Hologic Inc
· Qiagen NV · F. Hoffmann-La Roche Ltd · Abbott Laboratories · Biocare Medical LLC |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Human Papilloma Virus Tests Market Dynamics
The HPV tests market is influenced by several factors including changes in population size, management, and testing practices for genital warts cases, rising incidence and awareness of cervical cancer, and national screening programs.
Most HPV tests are sold for cervical cancer and pre-cancer screening purposes, meaning that the market opportunity for this device is heavily influenced by government policies and initiatives. While the North American HPV testing market is expected to remain strong during the forecast period, minimal growth is expected to occur in this region as well as APAC, South America, and the Middle East & Africa. Conversely, significant growth is also expected to occur in the European HPV testing market due to the rollout of national cancer screening programs in select key markets.
Human Papilloma Virus Tests Market Segmentation by Regions
The key regions in the HPV tests market are North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Europe will dominate the overall HPV tests market in 2023.
Strong growth is expected to occur in the European HPV tests market during the forecast period. Factors such as large increases in test sales in the German, Italian, UK, Norwegian, and Swedish markets owing to expected changes in government guidelines will drive the market growth. In addition to the markets, HPV testing is also used for the widespread screening of asymptomatic women in Spain and the Netherlands.
HPV Tests Market Analysis by Regions 2023 (%)
Buy the Full Report for More Insights into the Regions in HPV Tests Market
Human Papilloma Virus Tests Market Segments
The key segments in the HPV tests market are HPV (HPV) Nucleic Acid Amplification Tests (NAATs) and Other HPV (HPV) Test Kits. HPV (HPV) Nucleic Acid Amplification Tests (NAATs) led the market in 2023.
The HPV (HPV) Nucleic Acid Amplification Tests (NAATs) market includes both reverse hybridization procedures and enzyme PCR amplification devices. This method tests for the presence of human papillomavirus (HPV).
HPV Tests Market Analysis, by Segments 2023 (%)
Buy the Full Report for More Insights into the Segments in HPV Tests Market
Human Papilloma Virus Tests Market - Competitive Landscape
A few of the leading companies in the HPV tests market are:
- Hologic Inc
- Qiagen NV
- Hoffmann-La Roche Ltd
- Abbott Laboratories
- Biocare Medical LLC
Hologic Inc. dominated the market in 2023 followed by F. Hoffmann-La Roche Ltd.
HPV Tests Market Analysis, by Companies 2023 (%)
Buy the Full Report for More Insights into the Companies in HPV Tests Market
Segments Covered in the Report
HPV Tests Market Segments Outlook (Value, $ Million, 2015-2033)
- HPV (HPV) Nucleic Acid Amplification Tests (NAATs)
- Other HPV (HPV) Test Kits
HPV Tests Market Regional Outlook (Value, $ Million, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Inclusions
Currently marketed HPV tests and evolving competitive landscape:
Insightful review of the key industry trends.
- Annualized total HPV tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the HPV tests market.
- Competitive dynamics insights and trends provided for the HPV tests market.
Get detailed understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
Country-specific reimbursement policies. - Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Hologic Inc, Qiagen NV, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Biocare Medical LLC, Enzo Biochem Inc, Danaher Corp, Thermo Fisher Scientific Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This report provides:
- Insightful review of the key industry trends.
- Annualized total HPV tests market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the HPV tests market.
- Competitive dynamics insights and trends provided for the HPV tests market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Reasons to Buy
- Understand the impact of COVID-19 on the HPV tests market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the HPV tests market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the HPV tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific HPV tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Qiagen NV
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Biocare Medical LLC
Enzo Biochem Inc
Danaher Corp
Thermo Fisher Scientific Inc
Frequently asked questions
-
What is the HPV tests market size in 2023?
The HPV tests market size will be valued at $406.3 million in 2023.
-
Which region dominates the HPV tests market in 2023?
Europe will dominate the overall HPV tests market in 2023.
-
Which segment led the HPV tests market in 2023?
The HPV Nucleic Acid Amplification Tests (NAATs) segment led the market in 2023.
-
Which are the leading companies in the HPV tests market?
A few of the leading companies in the HPV tests market are Hologic Inc., Qiagen NV, F. Hoffmann-La Roche Ltd, Abbott Laboratories, and Biocare Medical LLC among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.